Jessica Keen is a Wellcome 4Ward North clinical PhD fellow, whose research focusses on the implementation of pharmacogenomic panel testing into systemic anti-cancer treatment pathways. Her PhD builds on the MSc in Genomic Medicine she completed in 2022 and a pre-doctoral research fellowship with the NIHR Applied Research Collaboration Greater Manchester.

Before starting her PhD, Jess was the Pharmacy Lead at the National Health Service (NHS) NorthWest Genomic Medicines Service Alliance in the UK, working to embed genomic medicine into routine clinical pathways and ensure equity of access to genomic testing and treatments for patients. She has particular interest in the role of pharmacy teams and the wider workforce in the implementation of pharmacogenomics in the NHS. She is an investigator on PROGRESS study (Delivering Pharmacogenetics in primary care for the NHS) and part of the NHS England Network of Excellence in Pharmacogenomics and Medicines Optimisation.

Her background is as an oncology pharmacist prescriber at the Christie NHS Foundation Trust in Manchester, where she specialised in Upper GI cancers and electronic prescribing. As a prescriber she has seen the benefit of genomics to inform treatment from diagnosis through to stratification and medicines optimisation. She is co-chair of the BOPA Genomic Medicine Advisory Group.